Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial [PDF]
Ruchong Chen +14 more
openalex +1 more source
Long-Term Clinical Remission on Benralizumab Treatment in Severe Eosinophilic Asthma: A Four-Year Real-Life Study. [PDF]
Quarato CMI +8 more
europepmc +1 more source
Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma. [PDF]
Somekawa K +19 more
europepmc +1 more source
Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo. [PDF]
Howell I +6 more
europepmc +1 more source
The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthma. [PDF]
Scortichini M +5 more
europepmc +1 more source
Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma. [PDF]
Menzella F +21 more
europepmc +1 more source
Case Report: Dual monoclonal antibody therapy in chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma-a proteome analysis. [PDF]
Blauwblomme M +12 more
europepmc +1 more source
Effects of benralizumab in patients with severe eosinophilic asthma (SEA): A plain language summary of the ANANKE study. [PDF]
Canonica GW +5 more
europepmc +1 more source

